Welcome to our dedicated page for OmniAb SEC filings (Ticker: OABIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OmniAb's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OmniAb's regulatory disclosures and financial reporting.
OmniAb, Inc. director John L. Higgins reported the vesting of 13,172 restricted stock units (RSUs) and the corresponding acquisition of 13,172 shares of common stock on January 30, 2026.
The RSUs vest in three substantially equal annual installments beginning January 30, 2024, conditioned on his continued service. After this transaction, he beneficially owns 2,942,320 shares of common stock and 20,000 RSUs directly.
OmniAb, Inc. director John L. Higgins reported the vesting of 13,172 restricted stock units (RSUs) and the corresponding acquisition of 13,172 shares of common stock on January 30, 2026.
The RSUs vest in three substantially equal annual installments beginning January 30, 2024, conditioned on his continued service. After this transaction, he beneficially owns 2,942,320 shares of common stock and 20,000 RSUs directly.
OmniAb, Inc. reports that its Board of Directors approved and adopted amended and restated bylaws effective January 30, 2026. The updated bylaws address the SEC’s universal proxy rules by clarifying that no one may solicit proxies for director nominees other than the Board’s nominees unless they comply with Rule 14a-19, including its notice and solicitation requirements.
The bylaws also modernize and enhance procedures for stockholder director nominations and other business at stockholder meetings, requiring additional background information and disclosures about proposing stockholders, proposed nominees, related persons, and their ownership of OmniAb securities. The filing notes further technical, modernizing and clarifying changes, with full text provided in attached exhibits.
OmniAb, Inc. reports that its Board of Directors approved and adopted amended and restated bylaws effective January 30, 2026. The updated bylaws address the SEC’s universal proxy rules by clarifying that no one may solicit proxies for director nominees other than the Board’s nominees unless they comply with Rule 14a-19, including its notice and solicitation requirements.
The bylaws also modernize and enhance procedures for stockholder director nominations and other business at stockholder meetings, requiring additional background information and disclosures about proposing stockholders, proposed nominees, related persons, and their ownership of OmniAb securities. The filing notes further technical, modernizing and clarifying changes, with full text provided in attached exhibits.
Schedule 13G/A filed for OmniAb, Inc. (OABI) discloses that several related entities and individuals report beneficial ownership of the issuer's common stock. Ash X LP and RLG GP each report ownership of 8,271,347 shares, representing approximately 5.8% of the outstanding common stock. RLG Capco II LLC holds 1,800,246 shares (about 1.3%) and Joel Greenblatt holds 1,428,571 shares (about 1.0%). Robert Goldstein is reported as beneficial owner of 10,071,593 shares (about 7.0%), reflecting combined holdings through entities he controls. The percentages are calculated using 122,701,294 shares outstanding as of July 30, 2025 plus 21,254,106 additional shares issued on August 25, 2025. The filing states the holdings are not intended to influence control of the issuer.